European Archives - Page 403 of 1444 - European Medical Journal

Sex Differences in Aortic Stenosis: The Role of Fibrosis

Myocardial fibrosis predicts mortality after aortic valve replacement, highlighting its importance for risk assessment in aortic stenosis.

New Treatment Approach Targets Diabetes-Related Microvascular Dysfunction

A novel heparanase inhibitor preserves vascular integrity in diabetes, preventing microvascular complications in the eye and kidney.

Decoding Epilepsy: Innovations, Misdiagnoses, and Game-Changing Therapies

This week, Jonathan sits down with Jacqueline French to explore groundbreaking innovations in epilepsy research, the challenges of misdiagnosis, and the transformative impact of advancements in clinical trial methodologies.

Preoperative Radiation Boost Enhances Immune Response in Breast Cancer

These findings suggest that a preoperative radiation therapy boost can safely induce a short-term increase in stromal tumour-infiltrating lymphocytes.

Contraceptive Counselling: A Discussion for Healthcare Professionals

This material has been developed and fully funded by Gedeon Richter. This is intended for healthcare professionals only (including UK)…

The Future of Food Allergy: Hugh Sampson

What initially drew you to the field of allergy and immunology, and how did your focus come to centre on food allergic disorders? I got…

Eli Lilly plans record $50bn US manufacturing investment

The company’s investment will expand its US manufacturing footprint and is the largest investment of its kind in history.

Copper Dysregulation Identified as Key Driver of Ageing

Increased copper activity contributes to ageing-related oxidative stress, but targeted chelation therapy may offer a promising intervention.

Teleneurorehabilitation: A Safe, Effective Alternative for Parkinson’s Treatment

Teleneurorehabilitation safely improves Parkinson’s symptoms and quality of life, offering a viable alternative to in-person therapy.

Cycling JAK Inhibitors More Effective Than Switching to Biologics in Rheumatoid Arthritis

New research suggests that cycling between JAK inhibitors may be more effective than switching to biologic DMARDs in rheumatoid arthritis patients who do not initially respond to JAKis.